Video

Safety of Closed-Loop Insulin Delivery System

Dr. Bobby Lazzara reviews the safety of a hybrid closed-loop insulin delivery system for patients with type 1 diabetes in a real-world setting.

Can a hybrid closed-loop insulin delivery system offer safe and effective treatment for patients with type 1 diabetes in a real-world setting? In this Medical News Minute, developed exclusively for Endocrinology Network, Dr. Bobby Lazzara reports on a study of the MiniMed 670G.

Related Videos
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.